Search in:

Expert Opinion on Drug Delivery Volume 6, 2009 - Issue 6

Submit an article Journal homepage

1,176

Views

166

CrossRef citations to date

Altmetric

Reviews

The potential for nanoparticle-based drug delivery to the brain: overcoming the blood–brain barrier

Eugen Barbu University of Portsmouth, School of Pharmacy and Biomedical Sciences, St Michael's Building, White Swan Road, Portsmouth PO1 2DT, UK +023 92 84 35 66; +023 92 84 35 65; [email protected]

Éva Molnàr University of Portsmouth, School of Pharmacy and Biomedical Sciences, St Michael's Building, White Swan Road, Portsmouth PO1 2DT, UK +023 92 84 35 66; +023 92 84 35 65; [email protected]

John Tsibouklis University of Portsmouth, School of Pharmacy and Biomedical Sciences, St Michael's Building, White Swan Road, Portsmouth PO1 2DT, UK +023 92 84 35 66; +023 92 84 35 65; [email protected]

Dariusz C Górecki University of Portsmouth, School of Pharmacy and Biomedical Sciences, St Michael's Building, White Swan Road, Portsmouth PO1 2DT, UK +023 92 84 35 66; +023 92 84 35 65; [email protected]

Pages 553-565 | Published online: 12 May 2009

Cite this article
https://doi.org/10.1517/17425240902939143

Full Article
Figures & data
References
Citations
Metrics
Reprints & Permissions

Bibliography

Jonssen B. Cost of disorders of the brain in Europe. Eur J Neurol 2005;12:8-9
Google Scholar
Zlokovic BV. The blood-brain barrier in health and chronic neurodegenerative disorders. NEURON CAMBRIDGE MA 2008;57:178-201
PubMed Web of Science ®Google Scholar
Silberberg D. Neurological disease on the global agenda. Ann Neurol 2008;64:475-6
PubMedGoogle Scholar
Pardridge WM. Drug targeting to the brain. Pharm Res 2007;24:1733-44
PubMed Web of Science ®Google Scholar
Pardridge WM. Blood-brain barrier delivery. Drug Discov Today 2007;12:54-61
PubMed Web of Science ®Google Scholar
Kaur IP, Bhandari R, Bhandari S, Kakkar V. Potential of solid lipid nanoparticles in brain targeting. J Control Release 2008;127:97-109
PubMed Web of Science ®Google Scholar
Abbott NJ, Ronnback L, Hansson E. Astrocyte-endothelial interactions at the blood-brain barrier. Nat Rev Neurosci 2006;7:41-53
PubMed Web of Science ®Google Scholar
Deli MA, Abraham CS, Kataoka Y, Niwa M. Permeability studies on in vitro blood-brain barrier models: physiology, pathology, and pharmacology. Cell Mol Neurobiol 2005;25:59-127
PubMed Web of Science ®Google Scholar
Butt AM, Jones HC, Abbott NJ. Electrical-resistance across the blood-brain-barrier in anesthetized rats – a developmental-study. J Physiol Lond 1990;429:47-62
Google Scholar
Garcia-Garcia E, Andrieux K, Gil S, Couvreur P. Colloidal carriers and Blood-Brain Barrier (Bbb) translocation: a way to deliver drugs to the brain? Int J Pharm 2005;298:274-92
PubMed Web of Science ®Google Scholar
Tosi G, Constantino L, Ruozi B, et al. Polymeric nanoparticles for the drug delivery to the central nervous system. Expert Opin Drug Deliv 2008;5:155-74
PubMed Web of Science ®Google Scholar
Wolburg H, Lippoldt A. Tight junctions of the blood-brain barrier: development, composition and regulation. Vascu Pharmacol 2002;38:323-37
PubMed Web of Science ®Google Scholar
Ricci M, Blasi P, Giovagnoli S, Rossi C. Delivering drugs to the central nervous system: a medicinal chemistry or a pharmaceutical technology issue? Curr Med Chem 2006;13:1757-75
PubMed Web of Science ®Google Scholar
Ohtsuki S, Terasaki T. Contribution of carrier-mediated transport systems to the blood-brain barrier as a supporting and protecting interface for the brain; importance for Cns drug discovery and development. Pharm Res 2007;24:1745-58
PubMed Web of Science ®Google Scholar
Bickel U, Yoshikawa T, Pardridge WM. Delivery of peptides and proteins through the blood-brain barrier. Adv Drug Deliv Rev 2001;46:247-79
PubMed Web of Science ®Google Scholar
Smith MW, Gumbleton M. Endocytosis at the blood-brain barrier: from basic understanding to drug delivery strategies. J Drug Target 2006;14:191-214
PubMed Web of Science ®Google Scholar
Miller DS, Bauer B, Hartz AMS. Modulation of P-Glycoprotein at the blood-brain barrier: opportunities to improve central nervous system pharmacotherapy. Pharmacol Rev 2008;60:196-209
PubMed Web of Science ®Google Scholar
Pardridge WM. Crossing the blood-brain barrier: are we getting it right? Drug Discov Today 2001;6:1-2
PubMed Web of Science ®Google Scholar
Kreuter J, Gelperina S. Use of nanoparticles for cerebral cancer. Tumori 2008;94:271-7
PubMed Web of Science ®Google Scholar
Prokop A, Davidson JM. Nanovehicular intracellular delivery systems. J Pharm Sci 2008;97:3518-90
PubMed Web of Science ®Google Scholar
Govender T, Ojewole E, Naidoo P, Mackraj I. Polymeric nanoparticles for enhancing antiretroviral drug therapy. Drug Deliv 2008;15:493-501
PubMed Web of Science ®Google Scholar
Juillerat-Jeanneret L. The targeted delivery of cancer drugs across the blood-brain barrier: chemical modifications of drugs or drug-nanoparticles? Drug Discov Today 2008;13:1099-106
PubMed Web of Science ®Google Scholar
Vauthier C, Labarre D, Ponchel G. Design aspects of poly(Alkylcyanoacrylate) nanoparticles for drug delivery. J Drug Target 2007;15:641-63
PubMed Web of Science ®Google Scholar
Micahelis K, Hoffmann MM, Dreis S, et al. Covalent linkage of apolipoprotein E to albumin nanoparticles strongly enhances drug transport into the brain. J Pharmacol Exp Ther 2006;317:1246-53
PubMed Web of Science ®Google Scholar
Kreuter J. Influence of the surface properties on nanoparticle-mediated transport of drugs to the brain. J Nanosci Nanotechnol 2004;4:484-8
PubMed Web of Science ®Google Scholar
Olivier JC. Drug transport to brain with targeted nanoparticles. NeuroRX 2005;2:108-19
PubMedGoogle Scholar
Wilson B, Samanta MK, Santhi K, et al. Targeted delivery of tacrine into the brain with polysorbate 80-coated poly(N-Butylcyanoacrylate) nanoparticles. Eur J Pharm Biopharm 2008;70:75-84
PubMed Web of Science ®Google Scholar
Wilson B, Samanta MK, Santhi K, et al. Poly(N-Butylcyanoacrylate) nanoparticles coated with polysorbate 80 for the targeted delivery of rivastigmine into the brain to treat Alzheimer's disease. Brain Res 2008;1200:159-68
PubMed Web of Science ®Google Scholar
Weiss CK, Kohnle MV, Landfester K, et al. The first step into the brain: uptake of Nio-Pbca nanoparticles by endothelial cells in vitro and in vivo, and direct evidence for their blood-brain barrier permeation. ChemMedchem 2008;3:1395-403
PubMed Web of Science ®Google Scholar
Reimold I, Domke D, Bender J, et al. Delivery of nanoparticles to the brain detected by fluorescence microscopy. Eur J Pharm Biopharm 2008;70:627-32
PubMed Web of Science ®Google Scholar
Schneider T, Becker A, Ringe K, et al. Brain tumor therapy by combined vaccination and antisense oligonucleotide delivery with nanoparticles. J Neuroimmunol 2008;195:21-7
PubMed Web of Science ®Google Scholar
O'Sullivan C, Birkinshaw C. Hydrolysis of poly (n-butylcyanoacrylate) nanoparticles using esterase. Polym Degradation Stability 2002;78:7-15
Web of Science ®Google Scholar
Kisich KO, Gelperina S, Higgins MP, et al. Encapsulation of moxifloxacin within poly(butyl cyanoacrylate) nanoparticles enhances efficacy against intracellular mycobacterium tuberculosis. Int J Pharm 2007;345:154-162
PubMed Web of Science ®Google Scholar
Lherm C, Müller RH, Puisieux F, Couvreur P. Alkylcyanoacrylate drug carriers: II. Cytotoxicity of cyanoacrylate nanoparticles with different alkyl chain length. Int J Pharm 1992;84:13-22
Web of Science ®Google Scholar
Vauthier C, Dubernet C, Fattal E, et al. Poly(Alkylcyanoacrylates) as biodegradable materials for biomedical applications. Adv Drug Deliv Rev 2003;55:519-48
PubMed Web of Science ®Google Scholar
Beduneau A, Saulnier P, Benoit JP. Active targeting of brain tumors using nanocarriers. Biomaterials 2007;28:4947-67
PubMed Web of Science ®Google Scholar
Wang HF, Hu Y, Guo T, et al. Inhibition of tissue factor expression in brain microvascular endothelial cells by nanoparticles loading Nf-kappa B decoy oligonucleotides. Int J Mol Sci 2008;9:1851-62
PubMed Web of Science ®Google Scholar
Cheng QY, Feng J, Li FZ. Brain delivery of neurotoxin-I-loaded nanoparticles through intranasal administration. Yao Xue Xue Bao 2008;43:431-4
PubMedGoogle Scholar
Liu MX, Li HF, Luo G, et al. Pharmacokinetics and biodistribution of surface modification polymeric nanoparticles. Arch Pharmacol Res 2008;31:547-54
PubMed Web of Science ®Google Scholar
Rao KS, Reddy MK, Horning JL, Labhasetwar V. Tat-conjugated nanoparticles for the Cns delivery of Anti-Hiv drugs. Biomaterials 2008;29:4429-38
PubMed Web of Science ®Google Scholar
Halder KK, Mandal B, Debnath MC, et al. Chloramphenicol-incorporated poly lactide-co-glycolide (Plga) nanoparticles: formulation, characterization, technetium-99m labeling and biodistribution studies. J Drug Target 2008;16:311-20
PubMed Web of Science ®Google Scholar
Pan J, Feng SS. Targeted delivery of paclitaxel using folate-decorated poly(Lactide) – vitamin E Tpgs nanoparticles. Biomaterials 2008;29:2663-72
PubMed Web of Science ®Google Scholar
Intra J, Salem AK. Characterization of the transgene expression generated by branched and linear polyethylenimine-plasmid Dna nanoparticles in vitro and after intraperitoneal injection in vivo. J Control Release 2008;130:129-38
PubMed Web of Science ®Google Scholar
Lavigne MD, Yates L, Coxhead P, Górecki DC. Nuclear-targeted chimeric vector enhancing nonviral gene transfer into skeletal muscle of fabry mice in vivo. FASEB J 2008;22:2097-107
PubMed Web of Science ®Google Scholar
Lavigne MD, Pennadam SS, Ellis J, et al. Enhanced gene expression through temperature profile-induced variations in molecular architecture of thermoresponsive polymer vectors. J Gene Med 2007;9:44-54
PubMed Web of Science ®Google Scholar
Pennadam SS, Ellis JS, Lavigne MD, et al. Synthesis and characterization of variable-architecture thermosensitive polymers for complexation With DNA. Langmuir 2007;23:41-9
PubMed Web of Science ®Google Scholar
Lavigne MD, Pohlschmidt M, Novo JF, et al. Promoter dependence of plasmid-pluronics targeted alpha galactosidase a expression in skeletal muscle of fabry mice. Mol Ther 2005;12:985-90
PubMed Web of Science ®Google Scholar
Ljubimova JY, Fujita M, Ljubimov AV, et al. Poly(Malic Acid) nanoconjugates containing various antibodies and oligo nucleotides for multitargeting drug delivery. Nanomed 2008;3:247-65
PubMed Web of Science ®Google Scholar
Ljubimova JY, Fujita M, Khazenzon NM, et al. Nanoconjugate based on polymalic acid for tumor targeting. Chemico Biol Interact 2008;171:195-203
PubMed Web of Science ®Google Scholar
Gilmore JL, Yi X, Quan L, Kabanov AV. Novel nanomaterials for clinical neuroscience. J Neuroimmune Pharmacol 2008;3:83-94
PubMed Web of Science ®Google Scholar
Wang XM, Chi N, Tang X. Preparation of estradiol chitosan nanoparticles for improving nasal absorption and brain targeting. Eur J Pharm Biopharm 2008;70:735-40
PubMed Web of Science ®Google Scholar
Ramakrishnan M, Wengenack TM, Kandimalla KK, et al. Selective contrast enhancement of individual Alzheimer's disease amyloid plaques using a polyamine and Gd-Dota conjugated antibody fragment against fibrillar a beta 42 for magnetic resonance molecular imaging. Pharm Res 2008;25:1861-72
PubMed Web of Science ®Google Scholar
Agyare EK, Curran GL, Ramakrishnan M, et al. Development of a smart nano-vehicle to target cerebrovascular amyloid deposits and brain parenchymal plaques observed in Alzheimer's disease and cerebral amyloid angiopathy. Pharm Res 2008;25:2674-84
PubMed Web of Science ®Google Scholar
Jallouli Y, Paillard A, Chang J, et al. Influence of surface charge and inner composition of porous nanoparticles to cross blood-brain barrier in vitro. Int J Pharm 2007;344:103-09
PubMed Web of Science ®Google Scholar
Kaur A, Jain S, Tiwary AK. Mannan-coated gelatin nanoparticles for sustained and targeted delivery of didanosine: in vitro and in vivo evaluation. Acta Pharmaceutica 2008;58:61-74
PubMed Web of Science ®Google Scholar
Kabanov AV, Gendelman HE. Nanomedicine in the diagnosis and therapy of neuro degenerative disorders. Prog Polym Sci 2007;32:1054-82
PubMed Web of Science ®Google Scholar
Gillies ER, Frechet JMJ. Dendrimers and dendritic polymers in drug delivery. Drug Discov Today 2005;10:35-43
PubMed Web of Science ®Google Scholar
Hughes GA. Nanostructure-mediated drug delivery. Dis Mon 2005;51:342-61
PubMed Web of Science ®Google Scholar
Dhanikula RS, Hammady T, Hildgen P, et al. On the mechanism and dynamics of uptake and permeation of polyether-copolyester dendrimers across an in vitro blood-brain barrier model. J Pharm Sci 2009;PMID:19156840. DOI: 10.1002/jps.21669.
Google Scholar
Blasi P, Giovagnoli S, Schoubben A, et al. Solid lipid nanoparticles for targeted brain drug delivery. Adv Drug Deliv Rev 2007;59:454-77
PubMed Web of Science ®Google Scholar
Muller RH, Rainer H, Keck CM, Cornelia M. Drug delivery to the brain–realization by novel drug carriers. J Nanosci Nanotechnol 2004;4:471-83
PubMed Web of Science ®Google Scholar
Wang D, Wang X, Li X, Ye L. Preparation and characterization of solid lipid nanoparticles loaded with alpha-asarone. J Pharm Sci Technol 2008;62:56-65
Google Scholar
Esposito E, Fantin M, Marti M, et al. Solid lipid nanoparticles as delivery systems for bromocriptine. Pharm Res 2008;25:1521-30
PubMed Web of Science ®Google Scholar
Li XW, Lin XH, Zheng LQ, et al. Preparation, characterization, and in vitro release of chloramphenicol loaded solid lipid nanoparticles. J Dispersion Sci Technol 2008;29:1214-21
Web of Science ®Google Scholar
Huang GH, Zhang N, Bi XL, Dou MJ. Solid lipid nanoparticles of temozolomide: potential reduction of cardial and nephric toxicity. Int J Pharm 2008;355:314-20
PubMed Web of Science ®Google Scholar
Doijad RC, Manvi FV, Godhwani DM, et al. Formulation and targeting efficiency of cisplatin engineered solid lipid nanoparticles. Indian J Pharm Sci 2008;70:203-7
PubMed Web of Science ®Google Scholar
Chattopadhyay N, Zastre J, Wong HL, et al. Solid lipid nanoparticles enhance the delivery of the Hiv protease inhibitor, atazanavir, by a human brain endothelial cell line. Pharm Res 2008;25:2262-71
PubMed Web of Science ®Google Scholar
Koo OM, Rubinstein I, Onyuksel H. Role of nanotechnology in targeted drug delivery and imaging: a concise review. Nanomed 2005;1:193-212
PubMed Web of Science ®Google Scholar
Linazasoro G. Potential applications of nanotechnologies to Parkinson's disease therapy. Parkinsonism Relat Disord 2008;14:383-92
PubMed Web of Science ®Google Scholar
Roy I, Stachowiak MK, Bergey EJ. Nonviral gene transfection nanoparticles: function and applications in the Brain. Nanomed 2008;4:89-97
PubMed Web of Science ®Google Scholar
Baoukina S, Monticelli L, Risselada HJ, et al. The molecular mechanism of lipid monolayer collapse. Proc Natl Acad Sci USA 2008;105:10803-8
PubMed Web of Science ®Google Scholar
Czeisler BM, Janigro D. Reading and writing the blood-brain barrier: relevance to therapeutics. Rec Patents Cns Drug Discov 2006;1:157-73
PubMedGoogle Scholar
Su Y, Sinko PJ. Drug delivery across the blood-brain barrier: why is it difficult? how to measure and improve it? Expert Opin Drug Deliv 2006;3:419-35
PubMed Web of Science ®Google Scholar
Batrakova EV, Li S, Vinogradov SV, et al. Mechanism of pluronic effect on P-glycoprotein efflux system in blood-brain barrier: contributions of energy depletion and membrane fluidization. J Pharmacol Exp Ther 2001;299:483-93
PubMed Web of Science ®Google Scholar
Batrakova EV, Kabanov AV. Pluronic block copolymers: evolution of drug delivery concept from inert nanocarriers to biological response modifiers. J Control Release 2008;130:98-106
PubMed Web of Science ®Google Scholar
Vinogradov SV, Batrakova EV, Kabanov AV. Nanogels for oligonucleotide delivery to the brain. Bioconjug Chem 2004;15:50-60
PubMed Web of Science ®Google Scholar
Pulkkinen M, Pikkarainen J, Wirth T, et al. Three-step tumor targeting of paclitaxel using biotinylated Pla-Peg nanoparticles and avidin-biotin technology: formulation development and in vitro anticancer activity. Eur J Pharm Biopharm 2008;70:66-74
PubMed Web of Science ®Google Scholar
Teixido M, Giralt E. The role of peptides in blood-brain barrier nanotechnology. J Pept Sci 2008;14:163-73
PubMedGoogle Scholar
Aktas Y, Yemisci M, Andrieux K, et al. Development and brain delivery of chitosan-peg nanoparticles functionalized with the monoclonal antibody Ox26. Bioconjug Chem 2005;16:1503-11
PubMed Web of Science ®Google Scholar
Mazza M, Uchegbu IF, Schatzlein AG. Cancer and the blood-brain barrier: ‘trojan horses’ for courses? Br J Pharmacol 2008;155:149-51
PubMed Web of Science ®Google Scholar
Karkan D, Pfeifer C, Vitalis TZ, et al. A unique carrier for delivery of therapeutic compounds beyond the blood-brain barrier. Plos One 2008;3:e2469
PubMed Web of Science ®Google Scholar
Regina A, Demeule M, Che C, et al. Antitumour activity of Ang1005, a conjugate between paclitaxel and the new brain delivery vector angiopep-2. Br J Pharmacol 2008;155:185-97
PubMed Web of Science ®Google Scholar
Solaro R. Targeted delivery of proteins by nanosized carriers. J Polym Sci A Polym Chem 2008;46:1-11
Web of Science ®Google Scholar
Huang RQ, Pei YY, Jiang C. Enhanced gene transfer into brain capillary endothelial cells using Antp-modified Dna-loaded nanoparticles. J Biomed Sci 2007;14:595-605
PubMed Web of Science ®Google Scholar
Sun C, Fang C, Stephen Z, et al. Tumor-targeted drug delivery and MRI contrast enhancement by chlorotoxin-conjugated iron oxide nanoparticles. Nanomed 2008;3:495-505
PubMed Web of Science ®Google Scholar
Lewis AL. PC technology as a platform for drug delivery: from combination to conjugation. Expert Opin Drug Deliv 2006;3:289-98
PubMed Web of Science ®Google Scholar
Xu G, Yong KT, Royi I, et al. Bioconjugated quantum rods as targeted probes for efficient transmigration across an in vitro blood-brain barrier. Bioconjug Chem 2008;19:1179-85
PubMed Web of Science ®Google Scholar
Gao XL, Wang T, Wu BX, et al. Quantum dots for tracking cellular transport of lectin-functionalized nanoparticles. Biochem Biophys Res Commun 2008;377:35-40
PubMed Web of Science ®Google Scholar
Sun C, Lee JSH, Zhang MQ. Magnetic nanoparticles in Mr imaging and drug delivery. Adv Drug Deliv Rev 2008;60:1252-65
PubMed Web of Science ®Google Scholar
Mccarthy JR, Weissleder R. Multifunctional magnetic nanoparticles for targeted imaging and therapy. Adv Drug Deliv Rev 2008;60:1241-51
PubMed Web of Science ®Google Scholar
De Jong WH, Borm PJA. Drug delivery and nanoparticles: applications and hazards. Int J Nanomed 2008;3:133-49
PubMed Web of Science ®Google Scholar
Buzea C, Pacheco II, Robbie K. Nanomaterials and nanoparticles: sources and toxicity. Biointerphases 2007;2:17-71
Web of Science ®Google Scholar
Politis M, Pilinis C, Lekkas TD. Ultrafine Particles (Ufp) and health effects. Dangerous. Like no other pm? Rev Anal Global Nest J 2008;10:439-52
Web of Science ®Google Scholar
Maccormack TJ, Goss GG. Identifying and predicting biological risks associated with manufactured nanoparticles in aquatic ecosystems. J Ind Ecol 2008;12:286-96
Web of Science ®Google Scholar
Prosie F, Lesage FX, Deschamps F. Nanoparticles: structures, utilizations and health impacts. Presse Med 2008;37:1431-37
PubMed Web of Science ®Google Scholar
Chen L, Yokel RA, Hennig B, Toborek M. Manufactured aluminum oxide nanoparticles decrease expression of tight junction proteins in brain vasculature. J Neuroimmune Pharmacol 2008;3:286-95
PubMed Web of Science ®Google Scholar
Tang JL, Xiong L, Wang S, et al. Influence of silver nanoparticles on neurons and blood-brain barrier via subcutaneous injection in rats. Appl Surface Sci 2008;255:502-4
Web of Science ®Google Scholar
Wu WH, Sun X, Yu YP, et al. Tio2 nanoparticles promote beta-amyloid fibrillation in vitro. Biochem Biophys Res Commun 2008;373:315-8
PubMed Web of Science ®Google Scholar
Lopez T, Recillas S, Guevara P, et al. Pt/Tio2 brain biocompatible nanoparticles: gbm treatment using the C6 model in wistar rats. Acta Biomaterialia 2008;4:2037-44
PubMed Web of Science ®Google Scholar
Kuo YC, Kuo CY. Electromagnetic interference in the permeability of saquinavir across the blood-brain barrier using nanoparticulate carriers. Int J Pharm 2008;351:271-81
PubMed Web of Science ®Google Scholar
Lynch I, Dawson KA. Protein-nanoparticle interactions. Nano Today 2008;3:40-7
Web of Science ®Google Scholar
Faunce TA, White J, Matthael KI. Integrated research into the nanoparticle-protein corona: a new focus for safe, sustainable and equitable development of nanomedicines. Nanomed 2008;3:859-66
PubMed Web of Science ®Google Scholar

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Share icon
Back to Top

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

The potential for nanoparticle-based drug delivery to the brain: overcoming the blood–brain barrier

Bibliography

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

The potential for nanoparticle-based drug delivery to the brain: overcoming the blood–brain barrier

Bibliography

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date